Anil P. Ranganath - 24 Feb 2025 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Senior Vice President, General Counsel and Secretary, Exhibit List: Exhibit 24 - Power of Attorney
Signature
By: /s/ Gerardo Hernandez, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
24 Feb 2025
Transactions value $
$0
Form type
4
Filing time
26 Feb 2025, 18:09:57 UTC
Previous filing
09 Aug 2024
Next filing
10 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Award $0 +5.63K +62.55% $0.00 14.6K 24 Feb 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +8.48K $0.00 8.48K 24 Feb 2025 Common Stock 8.48K $77.12 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 5,634 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 Includes 114 shares of Issuer's Common Stock acquired on December 31, 2024, pursuant to the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan ("ESPP"), for the option period of July 1, 2024 to December 31, 2024. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on December 31, 2024.
F3 The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service.

Remarks:

Senior Vice President, General Counsel and Secretary, Exhibit List: Exhibit 24 - Power of Attorney